Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2026 | Q1 | $1.1B | -- | -- | $0.56 | -- |
| 12/18/2025 | Q4 | $1.7B | $1.7B | $1.55 | $1.79 | -$0.24 |
| 09/24/2025 | Q3 | $1.6B | $1.6B | $1.61 | $1.49 | $0.12 |
| 06/23/2025 | Q2 | $1.5B | $1.5B | $1.50 | $1.46 | $0.04 |
| 03/24/2025 | Q1 | $1.5B | $1.4B | $1.49 | $1.58 | -$0.09 |
| 01/09/2025 | Q4 | $2B | $2B | $2.52 | $2.44 | $0.08 |
| 09/24/2024 | Q3 | $1.7B | $1.8B | $2.04 | $2.07 | -$0.03 |
| 06/18/2024 | Q2 | $1.7B | $1.7B | $2.15 | $1.81 | $0.34 |
| 03/20/2024 | Q1 | $1.5B | $1.5B | $1.76 | $1.57 | $0.19 |
| 01/10/2024 | Q4 | $1.6B | $1.7B | $1.85 | $1.68 | $0.17 |
| 09/20/2023 | Q3 | -- | $1.6B | $1.80 | -- | -- |
| 06/21/2023 | Q2 | -- | $1.8B | $1.94 | -- | -- |
| 03/22/2023 | Q1 | -- | $1.4B | $1.45 | -- | -- |
| 01/11/2023 | Q4 | -- | $1.9B | $2.47 | -- | -- |
| 09/21/2022 | Q3 | -- | $1.8B | $2.86 | -- | -- |
| 06/22/2022 | Q2 | -- | $1.7B | $2.32 | -- | -- |
| 03/23/2022 | Q1 | -- | $1.4B | $1.47 | -- | -- |
| 01/12/2022 | Q4 | -- | $1.7B | $1.91 | -- | -- |
| 09/22/2021 | Q3 | -- | $1.5B | $1.60 | -- | -- |
| 06/23/2021 | Q2 | -- | $1.4B | $1.50 | -- | -- |
| 03/24/2021 | Q1 | -- | $1.1B | $1.02 | -- | -- |
| 01/12/2021 | Q4 | -- | $1.2B | $1.12 | -- | -- |
| 09/22/2020 | Q3 | -- | $999M | $0.83 | -- | -- |
| 06/24/2020 | Q2 | -- | $914M | $0.55 | -- | -- |
| 03/26/2020 | Q1 | -- | $1.1B | $0.63 | -- | -- |
| 01/09/2020 | Q4 | -- | $1.6B | $1.31 | -- | -- |
| 09/25/2019 | Q3 | -- | $1.2B | $0.73 | -- | -- |
| 06/26/2019 | Q2 | -- | $1B | $0.51 | -- | -- |
| 03/26/2019 | Q1 | -- | $811.5M | $0.31 | -- | -- |
| 01/09/2019 | Q4 | -- | $1.3B | $0.96 | -- | -- |
| 09/25/2018 | Q3 | -- | $1.2B | $0.87 | -- | -- |
| 06/28/2018 | Q2 | -- | $1.1B | $0.57 | -- | -- |
| 03/22/2018 | Q1 | -- | $871.6M | -$0.82 | -- | -- |
| 01/10/2018 | Q4 | -- | $1.4B | $0.84 | -- | -- |
| 09/28/2017 | Q3 | -- | $1.1B | $0.51 | -- | -- |
| 06/27/2017 | Q2 | -- | $1B | $0.33 | -- | -- |
| 03/23/2017 | Q1 | -- | $818.6M | $0.15 | -- | -- |
| 01/11/2017 | Q4 | -- | $1.2B | $0.40 | -- | -- |
| 09/20/2016 | Q3 | -- | $913.3M | $0.42 | -- | -- |
| 06/21/2016 | Q2 | -- | $811.1M | $0.17 | -- | -- |
| 03/23/2016 | Q1 | -- | $678.4M | $0.14 | -- | -- |
KB Home reported $1.7B worth of top line sales in its most recent quarter.
KB Home announced earnings per share of $1.55 which represents a miss of analyst forecast a $1.79 per share.
KB Home reported $294.3M that represents $4.53 per share over the last quarter.
KB Home's earnings are forecast to decrease from $6.15 per share to $6.41 per share next year representing a decrease of -30.23%.
KB Home's next earnings date is March 24, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.